Poseida Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PSTX and buy or sell other stocks, ETFs, and their options commission-free!About PSTX
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T.
CEOKristin Yarema, PhD
CEOKristin Yarema, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees—
Employees—
PSTX Key Statistics
Market cap925.41M
Market cap925.41M
Price-Earnings ratio-15.00
Price-Earnings ratio-15.00
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.67
52 Week high$9.67
52 Week low$9.36
52 Week low$9.36
Stock Snapshot
Poseida Therapeutics(PSTX) stock is priced at $9.50, giving the company a market capitalization of 925.41M. It carries a P/E multiple of -15.00.
Poseida Therapeutics(PSTX) stock opened on 2025-12-13 at —. The price climbed to — and dipped to —.
Poseida Therapeutics(PSTX) shares are trading with a volume of 0.
In the last year, Poseida Therapeutics(PSTX) shares hit a 52-week high of $9.67 and a 52-week low of $9.36.
In the last year, Poseida Therapeutics(PSTX) shares hit a 52-week high of $9.67 and a 52-week low of $9.36.
People also own
Based on the portfolios of people who own PSTX. This list is generated using Robinhood data, and it’s not a recommendation.